{"id":"isoflurane-inhalant-product","safety":{"commonSideEffects":[{"rate":null,"effect":"Respiratory depression"},{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Bradycardia"},{"rate":null,"effect":"Postoperative nausea and vomiting"},{"rate":"<1","effect":"Malignant hyperthermia (rare)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Isoflurane acts primarily through potentiation of GABA-A receptors and inhibition of NMDA receptors, leading to widespread CNS depression. It also modulates other ion channels and neurotransmitter systems. The drug is administered via inhalation and rapidly crosses the blood-brain barrier to produce dose-dependent anesthesia, with quick onset and offset due to its volatile nature and low blood-gas solubility.","oneSentence":"Isoflurane is a volatile anesthetic that depresses the central nervous system by enhancing inhibitory neurotransmission and suppressing excitatory pathways, producing unconsciousness and analgesia.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:48:53.007Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"General anesthesia for surgical procedures"},{"name":"Maintenance of anesthesia during surgery"}]},"trialDetails":[{"nctId":"NCT04415060","phase":"PHASE3","title":"SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2020-06-15","conditions":"Covid19, Hypoxic Respiratory Failure","enrollment":800},{"nctId":"NCT05867472","phase":"PHASE3","title":"Advancing Brain Outcomes in Pediatric Critically Ill Patients Sedated With Volatile AnEsthestic Agents","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2023-10-10","conditions":"Intensive Care Units, Pediatric, Anesthetics, Inhalation, Mechanically Ventilated, Critically Ill Children","enrollment":60},{"nctId":"NCT06625606","phase":"NA","title":"Continuous Versus Single-Shot Spinal Anesthesia for Orthopedic Surgery","status":"COMPLETED","sponsor":"Benha University","startDate":"2024-09-01","conditions":"Post Operative Pain","enrollment":105},{"nctId":"NCT05993039","phase":"EARLY_PHASE1","title":"Inhalational Anesthesia vs TIVA in Endoscopic Tympanoplasty","status":"UNKNOWN","sponsor":"Our Lady of the Lake Hospital","startDate":"2023-09-01","conditions":"Perforated Eardrum","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":88,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Isoflurane Inhalant Product","genericName":"Isoflurane Inhalant Product","companyName":"Sunnybrook Health Sciences Centre","companyId":"sunnybrook-health-sciences-centre","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Isoflurane is a volatile anesthetic that depresses the central nervous system by enhancing inhibitory neurotransmission and suppressing excitatory pathways, producing unconsciousness and analgesia. Used for General anesthesia for surgical procedures, Maintenance of anesthesia during surgery.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}